The association between three promoter polymorphisms of IL-10 and inflammatory bowel diseases (IBD): A meta-analysis

References

• Kumar P. J., and M. L. Clark. 2002. Kumar & Clark clinical medicine, 5th ed. London: W. B. Saunders
   Google Scholar
• Melgar S., and F. Shanahan. 2010. Inflammatory bowel disease-from mechanisms to treatment strategies. Autoimmunity. 43:463–477
   PubMed Web of Science ®Google Scholar
• Orholm M., P. Munkholm, E. Langholz, et al. 1991. Familial occurrence of inflammatory bowel disease. New Engl. J. Med. 324:84–88
   PubMed Web of Science ®Google Scholar
• Breslin N. P., A. Todd, C. Kilgallen, and C. O'Morain. 1997. Monozygotic twins with Crohn's disease and ulcerative colitis: a unique case report. Gut. 41:557–560
   PubMed Web of Science ®Google Scholar
• Cavanaugh J. A., and P. Pavli. 1997. Ulcerative colitis: a genetic disease? Bailliere's Clin. Gastroenterol. 11:1–15
   PubMedGoogle Scholar
• Louis E., J. Satsangi, M. Roussomoustakaki, et al. 1996. Cytokine gene polymorphisms in inflammatory bowel disease. Gut. 39:705–710
   PubMed Web of Science ®Google Scholar
• Bioque G., J. B. Crusius, I. Koutroubakis, et al. 1995. Allelic polymorphism in IL-1 beta and IL-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel disease. Clin. Exp. Immunol. 102:379–383
   PubMed Web of Science ®Google Scholar
• Mansfield J. C., H. Holden, J. K. Tarlow, et al. 1994. Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology. 106:637–642
   PubMed Web of Science ®Google Scholar
• Tountas N. A., H. Yang, D. L. Coulter, et al. 1996. Increased carriage of allele 2 of IL-1 receptor antagonist (IL-1ra) in Jewish populations: the strongest known genetic association in ulcerative colitis. Gastroenterology. 110:A1029
   Web of Science ®Google Scholar
• Hugot J. P., M. Chamaillard, H. Zouali, et al. 2001. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411:599–603
   PubMed Web of Science ®Google Scholar
• Yamazaki K., D. McGovern, J. Ragoussis, et al. 2005. Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease. Human Mol. Genet. 14:3499–3506
   PubMed Web of Science ®Google Scholar
• Stoll M., B. Corneliussen, C. M. Costello, et al. 2004. Genetic variation in DLG5 is associated with inflammatory bowel disease. Nat. Genet. 36:476–480
   PubMed Web of Science ®Google Scholar
• Peltekova V. D., R. F. Wintle, L. A. Rubin, et al. 2004. Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat. Genet. 36:471–475
   PubMed Web of Science ®Google Scholar
• Newman B., X. Gu, R. Wintle, et al. 2005. A risk haplotype in the Solute Carrier Family 22A4/22A5 gene cluster influences phenotypic expression of Crohn's disease. Gastroenterology 128:260–269
   PubMed Web of Science ®Google Scholar
• Moore K. W., R. de Waal Malefyt, R. L. Coffman, and A. O'Garra. 2001. Interleukin-10 and the interleukin-10 receptor. Ann. Rev. Immunol. 19:683–765
   PubMed Web of Science ®Google Scholar
• Mosmann T. R. 1994. Properties and functions of interleukin-10. Adv. Immunol. 56:1–26
   PubMed Web of Science ®Google Scholar
• Taga K., and G. Tosato. 1992. IL-10 inhibits human T cell proliferation and IL-2 production. J. Immunol. 148:1143–1148
   PubMed Web of Science ®Google Scholar
• Eskdale J., P. Wordsworth, S. Bowman, et al. 1997. Association between polymorphisms at the human IL-10 locus and systemic lupus erythematosus. Tissue Anti. 49:635–639
   PubMed Web of Science ®Google Scholar
• Lee Y. H., S. J. Choi, J. D. Ji, and G. G. Song. 2012. Associations between interleukin-10 polymorphisms and susceptibility to psoriasis: a meta-analysis. Inflamm. Res. 61:657–663
   PubMed Web of Science ®Google Scholar
• Van Deventer S., C. Elson, and R. Fedorak. 1997. Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group. Gastroenterology. 113:383–389
   PubMed Web of Science ®Google Scholar
• Schreiber S., T. Heinig, H. G. Thiele, and A. Raedler. 1995. Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease. Gastroenterology. 108:1434–1444
   PubMed Web of Science ®Google Scholar
• Garza-Gonzalez E., G. I. Perez-Perez, S. I. Mendoza-Ibarra, et al. 2010. Genetic risk factors for inflammatory bowel disease in a North-eastern Mexican population. Int. J. Immunogenet. 37:355–359
   PubMed Web of Science ®Google Scholar
• Tedde A., A. Laura Putignano, S. Bagnoli, et al. 2008. Interleukin-10 promoter polymorphisms influence susceptibility to ulcerative colitis in a gender-specific manner. Scand. J. Gastroenterol. 43:712–718
   PubMed Web of Science ®Google Scholar
• Egger M., G. Davey Smith, M. Schneider, et al. 1997. Bias in meta-analysis detected by a simple, graphical test. Br. Med. J. 315:629–634
   PubMed Web of Science ®Google Scholar
• Colditz G. A., E. Burdick, and F. Mosteller. 1995. Heterogeneity in meta-analysis of data from epidemiologic studies: a commentary. Am. J. Epidemiol. 142:371–382
   PubMed Web of Science ®Google Scholar
• Higgins J. P., and S. G. Thompson. 2002. Quantifying heterogeneity in a meta-analysis. Stat. Med. 21:1539–1558
   PubMed Web of Science ®Google Scholar
• DerSimonian R., and N. Laird. 1986. Meta-analysis in clinical trials. Contr. Clin. Trials. 7:177–188
   PubMedGoogle Scholar
• Tagore A., W. M. Gonsalkorale, V. Pravica, et al. 1999. Interleukin-10 (IL-10) genotypes in inflammatory bowel disease. Tissue Anti. 54:386–390
   PubMedGoogle Scholar
• Klein W., A. Tromm, T. Griga, et al. 2000. The IL-10 gene is not involved in the predisposition to inflammatory bowel disease. Electrophoresis. 21:3578–3582
   PubMed Web of Science ®Google Scholar
• Koss K., J. Satsangi, G. C. Fanning, et al. 2000. Cytokine (TNF alpha, LT alpha and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: differential effects on production and allele frequencies. Genes. Immun. 1:185–190
   PubMed Web of Science ®Google Scholar
• Balding J., W. J. Livingstone, J. Conroy, et al. 2004. Inflammatory bowel disease: the role of inflammatory cytokine gene polymorphisms. Med. Inflam. 13:181–187
   PubMed Web of Science ®Google Scholar
• Cantor M. J., P. Nickerson, and C. N. Bernstein. 2005. The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease. Am. J. Gastroenterol. 100:1134–1142
   PubMed Web of Science ®Google Scholar
• Fernandez L., A. Martinez, J. L. Mendoza, et al. 2005. Interleukin-10 polymorphisms in Spanish patients with IBD. Inflam. Bowel Dis. 11:739–743
   PubMed Web of Science ®Google Scholar
• Fowler E. V., R. Eri, G. Hume, et al. 2005. TNFalpha and IL10 SNPs act together to predict disease behaviour in Crohn's disease. J. Med. Genet. 42:523–528
   PubMed Web of Science ®Google Scholar
• Klausz G., T. Molnár, F. Nagy, et al. 2005. Polymorphism of the heat-shock protein gene Hsp70-2, but not polymorphisms of the IL-10 and CD14 genes, is associated with the outcome of Crohn's disease. Scand. J. Gastroenterol. 40:1197–1204
   PubMed Web of Science ®Google Scholar
• Celik Y., U. Dagli, M. Y. Kilic, et al. 2006. Cytokine gene polymorphisms in Turkish patients with inflammatory bowel disease. Scand. J. Gastroenterol. 41:559–565
   PubMed Web of Science ®Google Scholar
• Hong J., E. Leung, A. G. Fraser, et al. 2008. IL4, IL10, IL16, and TNF polymorphisms in New Zealand Caucasian Crohn's disease patients. Int. J. Colorect. Dis. 23:335–337
   PubMed Web of Science ®Google Scholar
• Amre D. K., D. R. Mack, K. Morgan, et al. 2009. Interleukin 10 (IL-10) gene variants and susceptibility for paediatric onset Crohn's disease. Aliment. Pharmacol. Therapeut. 29:1025–1031
   PubMed Web of Science ®Google Scholar
• Sanchez R., E. Levy, F. Costea, and D. Sinnett. 2009. IL-10 and TNF-alpha promoter haplotypes are associated with childhood Crohn's disease location. World J. Gastroenterol.: WJG. 15:3776–3782
   PubMed Web of Science ®Google Scholar
• Andersen V., A. Ernst, J. Christensen, et al. 2010. The polymorphism rs3024505 proximal to IL-10 is associated with risk of ulcerative colitis and Crohns disease in a Danish case-control study. BMC Med. Genet. 11:82
   PubMed Web of Science ®Google Scholar
• Wang A. H., W. J. Lam, D. Y. Han, et al. 2011. The effect of IL-10 genetic variation and interleukin 10 serum levels on Crohn's disease susceptibility in a New Zealand population. Human Immunol. 72:431–435
   PubMed Web of Science ®Google Scholar
• Ahirwar D. K., P. Kesarwani, R. Singh, et al. 2012. Role of tumor necrosis factor-alpha (C-863A) polymorphism in pathogenesis of inflammatory bowel disease in Northern India. J. Gastrointest. Cancer. 43:196–204
   PubMedGoogle Scholar
• Nishimoto N. 2005. Cytokine signal regulation and autoimmune disorders. Autoimmunity. 38:359–367
   PubMed Web of Science ®Google Scholar
• Armstrong A. M., K. R. Gardiner, S. J. Kirk, et al. 1997. Tumour necrosis factor and inflammatory bowel disease. Br. J. Surgr. 84:1051–1058
   PubMed Web of Science ®Google Scholar
• van Hogezand R. A., and H. W. Verspaget. 1997. New therapies for inflammatory bowel disease: an update on chimeric anti-TNF alpha antibodies and IL-10 therapy. Scand. J. Gastroenterol. Suppl. 223:105–107
   PubMedGoogle Scholar
• Cominelli F., and T. T. Pizarro. 1996. Interleukin-1 and interleukin-1 receptor antagonist in inflammatory bowel disease. Aliment. Pharmacol. Therapeut. 10:49–53; discussion 4
   PubMed Web of Science ®Google Scholar
• Tarzi M., S. Klunker, C. Texier, et al. 2006. Induction of interleukin-10 and suppressor of cytokine signalling-3 gene expression following peptide immunotherapy. Clin. Exp. Allergy: J. Br. Soc. Allerg. Clin. Immunol. 36:465–474
   PubMed Web of Science ®Google Scholar
• Zhu H., X. Lei, Q. Liu, and Y. Wang. 2013. Interleukin-10-1082A/G polymorphism and inflammatory bowel disease susceptibility: a meta-analysis based on 17 585 subjects. Cytokine. 61:146–153
   PubMed Web of Science ®Google Scholar
• Nath S. K., J. B. Harley, and Y. H. Lee. 2005. Polymorphisms of complement receptor 1 and interleukin-10 genes and systemic lupus erythematosus: a meta-analysis. Human Genet. 118:225–234
   PubMed Web of Science ®Google Scholar
• Lee Y. H., S. C. Bae, S. J. Choi, et al. 2012. Associations between interleukin-10 polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis. Mol. Biol. Rep. 39:81–87
   PubMedGoogle Scholar